INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
Pomerantz LLP is investigating potential securities fraud claims against Omeros Corporation (NASDAQ: OMER) following a significant drop in its stock price. The investigation stems from the European Medicines Agency's negative opinion on Omeros's marketing authorization application for narsoplimab, leading to a 19.12% stock decline. …